New Directions In STD Treatment - University of Hawaii

More documents

Recommendations

Info

Nongonococcal Urethritis Issues � <strong>New</strong> etiologic agent: Mycoplasma genitalium � No change in diagnostic criteria � Treat for CT; azithromycin efficacy better for Mg � Recurrent/persistent NGU: � Consider trichomoniasis, prostatitis, non-infectious etiologies � Treat with metronidazole PLUS azithromycin if not used for initial infection � DELETED erythromycin for treating recurrent NGU
Cervicitis – Diagnostic Issues � Changed name from mucopurulent cervicitis (MPC) to cervicitis � M. genitalium, BV and douching may play a role in addition to CT, GC, trichomoniasis and HSV � Diagnostic criteria: endocervical mucopus OR cervical friability � Diagnosis: � Vaginal wet mount with >10 WBCs per HPF associated with CT and GC infection � Evaluate for PID, BV and trichomoniasis (culture if wet mount is negative) in addition to CT and GC
Page 1 and 2:
New Directions in STD Treatment: Hi
Page 3 and 4:
CDC 2006 STD Treatment Guidelines D
Page 5 and 6:
Challenging Management Dilemmas in
Page 7 and 8:
Sexual History Taking: The 5 P’s
Page 9 and 10: Recommend Nucleic Acid Amplificatio
Page 11 and 12: Percent Screened Estimated Chlamydi
Page 13 and 14: STD Screening for MSM STD Site Type
Page 15 and 16: Prevalence of rectal chlamydia and
Page 17 and 18: Prevalence of pharyngeal chlamydia
Page 19 and 20: C. trachomatis NAAT Testing …not
Page 21 and 22: Chlamydia Treatment in Pregnancy Re
Page 23 and 24: Percent 16 14 12 10 Infection Durin
Page 25 and 26: Provider Barriers to PDPT, CA 2002
Page 27 and 28: Gonorrhea Screening in Females �
Page 29 and 30: Percent of Neisseria gonorrhoeae Is
Page 31 and 32: Gonorrhea Treatment of Urogenital I
Page 33 and 34: Lymphogranuloma Venereum (LGV) C. t
Page 35 and 36: LGV Proctocolitis: Serologic Diagno
Page 37 and 38: Phil and the Penis on the Go
Page 39 and 40: The Three “R”s of Syphilis �
Page 41 and 42: Latent Syphilis � No clinical man
Page 43 and 44: Syphilis EIA Tests �Treponemal te
Page 45 and 46: Criteria for CSF Examination � Ne
Page 47 and 48: Syphilis Resistant to Azithromycin!
Page 51 and 52: HSV Issues � Role of type-specifi
Page 53 and 54: Rates of Transmission of HSV-2 to S
Page 55 and 56: Genital Herpes - Treatment Issues
Page 57 and 58: HPV Issues � Clarify uses of HPV
Page 59: Issues Regarding Anal Cancer Screen
Page 63 and 64: Pelvic Inflammatory Disease Issues
Page 65 and 66: PID: Oral Treatment Regimens Oral r
Page 67 and 68: Vaginitis Trichomonas Bacterial Vag
Page 69 and 70: Tinidazole: A New Treatment Option
Page 71 and 72: Proposed Management Trichomoniasis
Page 73 and 74: BV Treatment Recommended regimens:
Page 75: STD Resources California STD/HIV Pr
show all

New Directions In STD Treatment - University of Hawaii

Create successful ePaper yourself

Delete template?

Save as template?